To address this challenge, we designed DualL, by adding a second ligand, Tf, selective for TfRs, known to be over-expressed on the cell-surfaces of A2780 ovarian cancer cells (Koshkaryev et al., 2012; Sawant et al., 2013). Here, TF is linked to ovarian cancer.